Current policing and security challenges demand safer, more effective incapacitation solutions. Traditional “less-lethal” methods like OC/PAVA aerosols and pepper projectiles pose risks—unpredictable physiological responses, respiratory distress, ocular damage, and potential litigation. These methods can fail to incapacitate some individuals while causing severe injury to others.
Safe Defense Holdings' patent-pending Vision Impairment Solutions™ offers a truly non-lethal alternative. Designed for reliability, safety, and deployment in any environment, including public transit, schools, hospitals, retail spaces, government and commercial offices, and crowded or confined areas, our formulations safely, effectively, and reversibly impair vision using a synergistic combination of optical, sensory, and osmotic effects—without inflammatory agents. This ensures predictable, humane incapacitation with no risk to users, bystanders, or targets.
Our leadership team has a legacy of pioneering and optimizing revolutionary technologies in aerospace and medicine, from the B-2 Spirit stealth bomber to the first MRI whole body scanners. We’ve now applied that same expertise and commitment to creating safer, more effective incapacitation solutions that reduce risk and enhance operational capabilities in any environment.
We are engaging with chemical suppliers, contract manufacturers, investors, and early adopters who recognize the urgent need for better alternatives in public safety and security. Our solutions don’t just meet industry standards—they set new ones. Join us in transforming the landscape of non-lethal incapacitation.